These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19221866)

  • 1. Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility.
    Kim TY; Vigil D; Der CJ; Juliano RL
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):77-83. PubMed ID: 19221866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
    Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
    Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.
    Wheeler AP; Ridley AJ
    Exp Cell Res; 2004 Nov; 301(1):43-9. PubMed ID: 15501444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of Rho GTPase signaling.
    Croft DR; Olson MF
    Transcription; 2011; 2(5):211-5. PubMed ID: 22231116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse macrophages completely lacking Rho subfamily GTPases (RhoA, RhoB, and RhoC) have severe lamellipodial retraction defects, but robust chemotactic navigation and altered motility.
    Königs V; Jennings R; Vogl T; Horsthemke M; Bachg AC; Xu Y; Grobe K; Brakebusch C; Schwab A; Bähler M; Knaus UG; Hanley PJ
    J Biol Chem; 2014 Oct; 289(44):30772-30784. PubMed ID: 25213860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoA, RhoB and RhoC have different roles in cancer cell migration.
    Ridley AJ
    J Microsc; 2013 Sep; 251(3):242-9. PubMed ID: 23488932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.
    Tseliou M; Al-Qahtani A; Alarifi S; Alkahtani SH; Stournaras C; Sourvinos G
    Cell Physiol Biochem; 2016; 38(1):94-109. PubMed ID: 26741994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration.
    Kim TY; Healy KD; Der CJ; Sciaky N; Bang YJ; Juliano RL
    J Biol Chem; 2008 Nov; 283(47):32762-70. PubMed ID: 18786931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
    Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
    J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology.
    Eckenstaler R; Hauke M; Benndorf RA
    Biochem Pharmacol; 2022 Dec; 206():115321. PubMed ID: 36306821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.
    Al Haddad M; El-Rif R; Hanna S; Jaafar L; Dennaoui R; Abdellatef S; Miskolci V; Cox D; Hodgson L; El-Sibai M
    Cell Commun Signal; 2020 Sep; 18(1):144. PubMed ID: 32900380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling.
    Zhang K; Na T; Ge F; Yuan BZ
    Exp Cell Res; 2020 Jan; 386(2):111732. PubMed ID: 31770531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases.
    Asnaghi L; Vass WC; Quadri R; Day PM; Qian X; Braverman R; Papageorge AG; Lowy DR
    Oncogene; 2010 May; 29(19):2760-71. PubMed ID: 20228844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
    Sun J; Barbieri JT
    J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.
    Arthur WT; Ellerbroek SM; Der CJ; Burridge K; Wennerberg K
    J Biol Chem; 2002 Nov; 277(45):42964-72. PubMed ID: 12221096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GRAF family member oligophrenin1 is a RhoGAP with BAR domain and regulates Rho GTPases in platelets.
    Elvers M; Beck S; Fotinos A; Ziegler M; Gawaz M
    Cardiovasc Res; 2012 Jun; 94(3):526-36. PubMed ID: 22298643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB.
    García-Mariscal A; Li H; Pedersen E; Peyrollier K; Ryan KM; Stanley A; Quondamatteo F; Brakebusch C
    Oncogene; 2018 Feb; 37(7):847-860. PubMed ID: 29059167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho regulation: DLC proteins in space and time.
    Braun AC; Olayioye MA
    Cell Signal; 2015 Aug; 27(8):1643-51. PubMed ID: 25889896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A built-in arginine finger triggers the self-stimulatory GTPase-activating activity of rho family GTPases.
    Zhang B; Zhang Y; Collins CC; Johnson DI; Zheng Y
    J Biol Chem; 1999 Jan; 274(5):2609-12. PubMed ID: 9915787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.